VIICTR Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (2)
A potential role for immunotherapy in thyroid cancer by enhancing NY-ESO-1 cancer antigen expression.
Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expression.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A potential role for immunotherapy in thyroid cancer by enhancing NY-ESO-1 cancer antigen expression.
A potential role for immunotherapy in thyroid cancer by enhancing NY-ESO-1 cancer antigen expression. Thyroid. 2014 Aug; 24(8):1241-50.
View in:
PubMed
subject areas
Animals
Antigens, Neoplasm
Azacitidine
Cell Line, Tumor
Coculture Techniques
Cytoplasm
Gene Expression Regulation
Gene Expression Regulation, Neoplastic
Granzymes
Humans
Immunotherapy
Interferon-gamma
Lymphocytes
Membrane Proteins
Methylation
Mice
Mice, SCID
Neoplasm Metastasis
Polymerase Chain Reaction
Receptors, Antigen, T-Cell
RNA, Messenger
Thyroid Neoplasms
authors with profiles
JENNIFER WARGO